NCT04274335View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of Tranexamic Acid in Women Having Caesarean Section Birth [WOMAN-PharmacoTXA]

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

September 30, 2021

Conditions
Pregnancy, High Risk
Interventions
DRUG

Tranexamic Acid 100Mg/Ml Inj Vil 10Ml

1 gram of tranexamic acid to be administered intravenously

DRUG

Tranexamic Acid Oral Solution

4 grams of tranexamic acid given as an oral solution

DRUG

Tranexamic Acid Injectable Product

1 gram of tranexamic acid given as 2 separate intramuscular injection

Trial Locations (2)

Unknown

MCH PIMS, Islamabad

Women and Newborn Hospital, Lusaka

All Listed Sponsors
collaborator

Rawalpindi Medical College

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT04274335 - Pharmacokinetics and Pharmacodynamics of Tranexamic Acid in Women Having Caesarean Section Birth [WOMAN-PharmacoTXA] | Biotech Hunter | Biotech Hunter